Anhui Anke BioTech Group (300009) — Net Asset Quality Index
Anhui Anke BioTech Group (300009) has a Net Asset Quality Index of 86.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.13 Billion minus total liabilities of CN¥714.45 Million yields net assets of CN¥4.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Anhui Anke BioTech Group debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Anhui Anke BioTech Group Net Asset Quality Index Over Time (2006–2025)
This chart shows how Anhui Anke BioTech Group's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of June 2026, the index stands at 86.1%, representing net assets of CN¥4.41 Billion against total assets of CN¥5.13 Billion CNY. For live market cap and overall valuation, see how much is Anhui Anke BioTech Group worth.
Annual Net Asset Quality Index for Anhui Anke BioTech Group (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Anhui Anke BioTech Group from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Anhui Anke BioTech Group (300009) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.4% | CN¥4.74 Billion | CN¥5.55 Billion | CN¥811.30 Million | ▲ +1.6 pp |
| 2024 | 83.7% | CN¥4.30 Billion | CN¥5.14 Billion | CN¥835.41 Million | ▲ +4.3 pp |
| 2023 | 79.4% | CN¥3.93 Billion | CN¥4.95 Billion | CN¥1.02 Billion | ▼ -0.5 pp |
| 2022 | 79.9% | CN¥3.40 Billion | CN¥4.26 Billion | CN¥855.17 Million | ▲ +0.8 pp |
| 2021 | 79.1% | CN¥2.90 Billion | CN¥3.67 Billion | CN¥765.52 Million | ▼ -3.9 pp |
| 2020 | 83.0% | CN¥2.93 Billion | CN¥3.53 Billion | CN¥600.29 Million | ▼ -0.7 pp |
| 2019 | 83.7% | CN¥2.70 Billion | CN¥3.23 Billion | CN¥526.19 Million | ▲ +4.1 pp |
| 2018 | 79.6% | CN¥2.01 Billion | CN¥2.53 Billion | CN¥515.86 Million | ▲ +1.5 pp |
| 2017 | 78.1% | CN¥1.76 Billion | CN¥2.25 Billion | CN¥493.73 Million | ▲ +5.5 pp |
| 2016 | 72.6% | CN¥1.43 Billion | CN¥1.97 Billion | CN¥539.04 Million | ▼ -18.3 pp |
| 2015 | 90.9% | CN¥1.26 Billion | CN¥1.39 Billion | CN¥126.48 Million | ▲ +6.4 pp |
| 2014 | 84.5% | CN¥773.47 Million | CN¥915.58 Million | CN¥142.11 Million | ▼ -3.6 pp |
| 2013 | 88.1% | CN¥660.60 Million | CN¥749.81 Million | CN¥89.21 Million | ▼ -0.7 pp |
| 2012 | 88.8% | CN¥580.03 Million | CN¥652.93 Million | CN¥72.91 Million | ▼ -1.3 pp |
| 2011 | 90.1% | CN¥543.88 Million | CN¥603.65 Million | CN¥59.77 Million | ▲ +1.5 pp |
| 2010 | 88.6% | CN¥522.30 Million | CN¥589.55 Million | CN¥67.25 Million | ▼ -2.8 pp |
| 2009 | 91.3% | CN¥495.41 Million | CN¥542.36 Million | CN¥46.95 Million | ▲ +24.7 pp |
| 2008 | 66.7% | CN¥148.64 Million | CN¥222.96 Million | CN¥74.32 Million | ▲ +8.7 pp |
| 2007 | 58.0% | CN¥137.09 Million | CN¥236.55 Million | CN¥99.46 Million | ▲ +3.9 pp |
| 2006 | 54.0% | CN¥122.00 Million | CN¥225.72 Million | CN¥103.72 Million | — |